Pharmacokinetic Interactions between Antiepileptic and Antidepressant Drugs

References

• Andersen B B, Mikkelsen M, Vesterager A, Dam M, Kristensen H B, Pedersen B, Lund J, Mengel H. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res 1991; 10: 201–204
   PubMed Web of Science ®Google Scholar
• Bonate P L, Kroboth P D, Smith R B, Suarez E, Oo C. Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. J Clin Psychopharmacol 2000; 20: 19–27
   PubMedGoogle Scholar
• Fehr C, Grunder G, Hiemke C, Dahmen N. Increase in serum clomipramine concentrations caused by valproate. J Clin Psychopharmacol 2000; 20: 493–494
   PubMed Web of Science ®Google Scholar
• Gidal B E, Anderson G D, Seaton T L, Miyoshi H R, Wilenksy A J. Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide. Ther Drug Monit 1993; 15: 405–409
   PubMedGoogle Scholar
• Grimsley S R, Jann M W, Carter J G, D'Maello A P, D'Souza M J. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 1991; 50: 10–15
   PubMed Web of Science ®Google Scholar
• Haselberger M B, Freedman L S, Tolbert S. Elevated serum phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 1997; 17: 107–109
   PubMedGoogle Scholar
• Kaufman K R, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure 1998; 7: 163–165
   PubMed Web of Science ®Google Scholar
• Ketter T A, Post R M, Parekh P I, Worthington K. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. J Clin Psychiatry 1995; 56: 471–475
   PubMed Web of Science ®Google Scholar
• Laroudie C, Salazar D E, Cosson J P, Cheuvart B, Istin B, Girault J, Ingrand I, Decourt J P. Carbamazepine-nefazodone interaction in healthy subjects. J Clin Psychopharmacol 2000; 20: 46–53
   PubMed Web of Science ®Google Scholar
• Leinonen E, Lepola U, Koponen H. Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases. Pharmacopsychiatry 1996; 29: 156–158
   PubMed Web of Science ®Google Scholar
• Nawishy S, Hathaway N, Turner P. Interactions of anticonvulsant drugs with mianserin and nomifensine. Lancet 1981; 2: 871–872
   PubMed Web of Science ®Google Scholar
• Nelson D R, Koymans L, Kamataki T, Stegemn J J, Feyereisen R, Waxman D J, Waterman M R, Gotoh O, Coon M J, Estabroon R W, Gunsalus I C, Nebert D W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–42
   PubMedGoogle Scholar
• Nelson M H, Birnbaum A K, Remmel R P. Inhibition of phenyotin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res 2001; 44: 71–82
   PubMed Web of Science ®Google Scholar
• Nemeroff C B, De Vane C L, Pollock B G. Newer antidepressants and cytochrome P450 system. Am J Psychiatry 1996; 153: 311–320
   PubMed Web of Science ®Google Scholar
• Odishaw J, Chen C. Effects of steady state bupropion on the pharmacokinetics of lamotrigine in healthy subjects. Pharamcotherapy 2000; 20: 1448–1453
   PubMed Web of Science ®Google Scholar
• Perucca E, Manzo L, Crema A. Pharmacokinetic interactions between antiepileptic and psychotropic drugs. The psychopharmacology of epilepsy, MR Trimble. John Wiley & Sons, London 1985; 95–-105
   Google Scholar
• Popli A P, Tanquary J, Lamparella V, Masand P S. Bupropion and anticonvulsant drug interactions. Ann Clin Psychiatry 1995; 7: 99–101
   PubMedGoogle Scholar
• Rapeport W G, Muirhead D C, Williams S A, Cross M, Wesnes K. Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin. J Clin Psychiatry 1996a; 57(Suppl 1)24–28
   PubMedGoogle Scholar
• Rapeport W G, Williams S A, Muirhead D C, Dewland P M, Tanner T, Wesnes K. Absence of sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry 1996b; 57(Suppl 1)20–23
   PubMed Web of Science ®Google Scholar
• Sitsen J, Maris F, Timmer C. Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects. Eur J Drug Metab Phamacokinet 2001; 26: 109–121
   Google Scholar
• Spina E, Avenoso A, Pollicino A M, Caputi A P, Fazio A, Pisani F. Carbamazepine coadministration with fluoxetine or fluvoxamine. Ther Drug Monit 1993; 15: 247–250
   PubMed Web of Science ®Google Scholar
• Szymura-Oleksiak J, Wyska E, Wasieczko A. Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression. Psychopharmacology (Berl) 2001; 154: 38–42
   PubMed Web of Science ®Google Scholar
• Tekle A, al-Kamis K I. Phenytoin-bupropion interaction: effect on plasma phenytoin concentration in the rat. J Pharm Pharmacol 1990; 42: 799–801
   PubMedGoogle Scholar
• Wong S L, Cavanaugh J, Shi H, Awni W M, Granneman G R. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics. Clin Pharmacol Ther 1996; 60: 48–53
   PubMed Web of Science ®Google Scholar
• Van Belle K, Sarre S, Ebinger G, Michotte Y. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study. J Pharmacol Exp Ther 1995; 272: 1217–1222
   PubMed Web of Science ®Google Scholar